Read the guidance on examining patients at risk from glaucoma
This member briefing covers the guideline on Glaucoma: diagnosis and management
Find out more about getting a College-accredited higher qualification in glaucoma.
Deborah Bott is the first author of the winning entry of the 2024 College of Optometrists Early Career Researchers Poster Competition.
In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.
Clinical files: What impact should a patient's home genetics test have on my clinical decision-making?
Evidence suggests that obstructive sleep apnoea increases the risk of normal-tension glaucoma writes Kim Thomas, but is there a causal mechanism?
Welcome to the UK's leading optometry conference!
Clinical files: Is it appropriate for me to treat steroid-related rises in IOP where the steroid was originally used for managing anterior uveitis, even though I do not have any additional glaucoma qualifications?
A short presentation on Van Herick and Goldman applanation tonometry techniques followed by a hands on skills workshop.
This discussion workshop includes techniques to assess anterior chamber angle and analysis of images.
This session will explore recent advancements in the understanding of the relationship between structural imaging and perimetry.
New NICE guidance states that selective laser trabeculoplasty rather than eye drops should be a first-line treatment for glaucoma. Kim Thomas asks what this means for optometrists – and their patients.
Clinical files: Can I routinely use an OCT instead of a visual field test for detecting chronic COAG?
For the very last issue of Optometry in Practice, Professor Jonathan Jackson MCOptom reflects on the past two decades of the journal and its contribution to our learning.
In this article three interesting glaucoma cases are discussed alongside the evidence-based approach underpinning management decisions.
This case study shows how selective laser trabeculoplasty (SLT) resulted in an improvement in ocular symptoms in a patient with ocular surface disease secondary to treatment for glaucoma.